Literature DB >> 17428865

Characterization and experimental transmission of an oncogenic papillomavirus in female macaques.

Charles E Wood1, Zigui Chen, J Mark Cline, Brigitte E Miller, Robert D Burk.   

Abstract

Cervical cancer is one of the leading causes of cancer mortality in women worldwide, yet few suitable animal models currently exist for study of this disease. Virtually all cases of cervical cancer in women are caused by specific types of genital human papillomavirus (HPV). In this study, we investigated naturally occurring genital PVs in female cynomolgus macaques (Macaca fascicularis) without breeding contact for at least 3.5 years. Exfoliated cervicovaginal cells from 19 of 54 animals tested positive for at least one PV. Seven different PVs were identified, including four novel genotypes and two genotypes (RhPV-d and RhPV-a) previously identified in rhesus macaques (Macaca mulatta). Four PV types were associated with cervical intraepithelial neoplasia (CIN), which resembled human CIN by endoscopy, cervical cytology, histology, and immunohistochemistry. The presence of CIN was highly associated with PV infection (P<0.0001). The most prevalent virus type was RhPV-d, which was identified in 60% of animals with CIN. An RhPV-d genome sequenced from a high-grade CIN lesion was found to be phylogenetically related to the highly oncogenic HPV16. Transfer of cervical cytobrush samples from donor animals naturally carrying RhPV-d resulted in new infections in 4 of 12 previously virus-free animals and abnormal cytology and histology in 1 of 4 infected animals after 18 weeks of infection. Experimental transmission was confirmed by E1/\E4 reverse transcription-PCR products and RhPV-d sequence identity with the donor variant. These findings identify key similarities between macaque and human oncogenic PVs which should prove useful in the study of viral persistence, carcinogenesis, and therapeutic development.

Entities:  

Mesh:

Year:  2007        PMID: 17428865      PMCID: PMC1900122          DOI: 10.1128/JVI.00233-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

1.  Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females.

Authors:  A B Moscicki; N Hills; S Shiboski; K Powell; N Jay; E Hanson; S Miller; L Clayton; S Farhat; J Broering; T Darragh; J Palefsky
Journal:  JAMA       Date:  2001-06-20       Impact factor: 56.272

Review 2.  How will HPV vaccines affect cervical cancer?

Authors:  Richard Roden; T-C Wu
Journal:  Nat Rev Cancer       Date:  2006-10       Impact factor: 60.716

3.  Epidemiologic classification of human papillomavirus types associated with cervical cancer.

Authors:  Nubia Muñoz; F Xavier Bosch; Silvia de Sanjosé; Rolando Herrero; Xavier Castellsagué; Keerti V Shah; Peter J F Snijders; Chris J L M Meijer
Journal:  N Engl J Med       Date:  2003-02-06       Impact factor: 91.245

Review 4.  Animal models of papillomavirus pathogenesis.

Authors:  M Saveria Campo
Journal:  Virus Res       Date:  2002-11       Impact factor: 3.303

5.  Cervical and vaginal epithelial neoplasms in cynomolgus monkeys.

Authors:  C E Wood; H Borgerink; T C Register; L Scott; J M Cline
Journal:  Vet Pathol       Date:  2004-03       Impact factor: 2.221

Review 6.  Classification of papillomaviruses.

Authors:  Ethel-Michele de Villiers; Claude Fauquet; Thomas R Broker; Hans-Ulrich Bernard; Harald zur Hausen
Journal:  Virology       Date:  2004-06-20       Impact factor: 3.616

Review 7.  Chapter 2: Natural history of anogenital human papillomavirus infection and neoplasia.

Authors:  Mark Schiffman; Susanne Krüger Kjaer
Journal:  J Natl Cancer Inst Monogr       Date:  2003

Review 8.  Chapter 3: Cofactors in human papillomavirus carcinogenesis--role of parity, oral contraceptives, and tobacco smoking.

Authors:  Xavier Castellsagué; Nubia Muñoz
Journal:  J Natl Cancer Inst Monogr       Date:  2003

Review 9.  Chapter 5: Viral and host factors in human papillomavirus persistence and progression.

Authors:  Sophia S Wang; Allan Hildesheim
Journal:  J Natl Cancer Inst Monogr       Date:  2003

10.  Life cycle heterogeneity in animal models of human papillomavirus-associated disease.

Authors:  Woei Ling Peh; Kate Middleton; Neil Christensen; Philip Nicholls; Kiyofumi Egawa; Karl Sotlar; Janet Brandsma; Alan Percival; Jon Lewis; Wen Jun Liu; John Doorbar
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

View more
  28 in total

1.  Novel betapapillomavirus associated with hand and foot papillomas in a cynomolgus macaque.

Authors:  C E Wood; S H Tannehill-Gregg; Z Chen; K van Doorslaer; D R Nelson; J M Cline; R D Burk
Journal:  Vet Pathol       Date:  2010-10-04       Impact factor: 2.221

2.  Novel genital alphapapillomaviruses in baboons (Papio hamadryas anubis) with cervical dysplasia.

Authors:  I L Bergin; J D Bell; Z Chen; M K Zochowski; D Chai; K Schmidt; D L Culmer; D M Aronoff; D L Patton; J M Mwenda; C E Wood; R D Burk
Journal:  Vet Pathol       Date:  2012-03-23       Impact factor: 2.221

3.  Human papillomavirus genomics: past, present and future.

Authors:  Ariana Harari; Zigui Chen; Robert D Burk
Journal:  Curr Probl Dermatol       Date:  2014-03-13

4.  Effect of Pap smear collection and carrageenan on cervicovaginal human papillomavirus-16 infection in a rhesus macaque model.

Authors:  Jeffrey N Roberts; Rhonda C Kines; Hormuzd A Katki; Douglas R Lowy; John T Schiller
Journal:  J Natl Cancer Inst       Date:  2011-04-11       Impact factor: 13.506

5.  Spontaneous cervicovaginal lesions and immune cell infiltrates in nonhuman primates.

Authors:  Carole E Harbison; Mary E Ellis; Susan V Westmoreland
Journal:  Toxicol Pathol       Date:  2013-02-20       Impact factor: 1.902

6.  Urogenital Lesions in Nonhuman Primates at 2 National Primate Research Centers.

Authors:  Shannon Kirejczyk; Christopher Pinelli; Olga Gonzalez; Shyamesh Kumar; Edward Dick; Sanjeev Gumber
Journal:  Vet Pathol       Date:  2020-11-19       Impact factor: 2.221

7.  Human and primate tumour viruses use PDZ binding as an evolutionarily conserved mechanism of targeting cell polarity regulators.

Authors:  V Tomaić; D Gardiol; P Massimi; M Ozbun; M Myers; L Banks
Journal:  Oncogene       Date:  2008-09-29       Impact factor: 9.867

8.  Genomic diversity and interspecies host infection of alpha12 Macaca fascicularis papillomaviruses (MfPVs).

Authors:  Zigui Chen; Koenraad van Doorslaer; Rob DeSalle; Charles E Wood; Jay R Kaplan; Janice D Wagner; Robert D Burk
Journal:  Virology       Date:  2009-08-28       Impact factor: 3.616

Review 9.  Recent advances in strategies for immunotherapy of human papillomavirus-induced lesions.

Authors:  Shreya Kanodia; Diane M Da Silva; W Martin Kast
Journal:  Int J Cancer       Date:  2008-01-15       Impact factor: 7.396

10.  Consensus-degenerate hybrid oligonucleotide primers (CODEHOPs) for the detection of novel viruses in non-human primates.

Authors:  Jeannette P Staheli; Jonathan T Ryan; A Gregory Bruce; Richard Boyce; Timothy M Rose
Journal:  Methods       Date:  2009-05-27       Impact factor: 3.608

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.